Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells.

导出 LinkOut

翻译打印收藏纠错

作者： Farheen,Fatima Qizilbash ^[1] ; Ali,Sartaj ^[1] ; Zufika,Qamar ^[2] ; Shobhit,Kumar ^[1] ; Mohammad,Imran ^[3] ; Yousuf,Mohammed ^[4] ; Javed,Ali ^[4] ; Sanjula,Baboota ^[5] ; Asgar,Ali ^[1]

作者单位： Department of Pharmaceutics, School of Pharmaceutical Education and Research, New Delhi, India. ^[1] Lloyd School of Pharmacy, Greater Noida, India. ^[2] Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology (MIET), Meerut, India. ^[3] Therapeutics Research Group, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia. ^[4] School of Pharmacy, The University of Queensland, Brisbane, Australia. ^[5]

关键词 Breast cancer liposomes multi-drug resistance (MDR)nanoemulsion (NE)nanostructured lipid carriers (NLCs)solid-lipid nanoparticles (SLNs)

DOI 10.1080/1061186X.2023.2243403

PMID 37525966

发布时间 2023-09-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交